Psychedelic Neuroplasticity and the GL Phase Transition¶

Jean-Paul Niko · RTSG BuildNet · 2026

Abstract¶

We present a GL framework for psychedelic therapy, showing that psychedelic compounds induce controlled approach to the GL critical point (\(\lambda \approx 0\)) without full condensate collapse. The default mode network (DMN) dissolution reported under psilocybin and LSD corresponds to condensate softening — temporary reduction of \(W_0\) that permits structural reorganization. MDMA-assisted therapy is social filter recalibration, ketamine is rapid condensate reset (explaining its fast antidepressant action), and microdosing is subcritical \(\alpha\) modulation. Integration after the session is condensate reformation with new structure. The framework connects psychedelic therapy to the same GL action governing cancer (ATRA restores cellular condensate) and aging (condensate erosion).

1. The Therapeutic Window as GL Phase Transition¶

\[S[W] = \int \left( |\partial W|^2 + \alpha|W|^2 + \frac{\beta}{2}|W|^4 \right) d\mu\]

Mental health conditions are often stuck condensates — rigid patterns of thought, feeling, and behavior maintained by a deep GL energy minimum. The therapeutic challenge: how to restructure without destroying.

Psychedelics solve this by temporarily reducing the barrier height \(\Delta E\), pushing the system toward the critical point where reorganization is possible but collapse is not yet reached.

Compound	GL Mechanism	Filter Target
Psilocybin/LSD	Global \(\alpha\) perturbation → DMN softening	All filters simultaneously
MDMA	Social filter recalibration (\(\alpha_{\text{social}}\) modulation)	Social mask / attachment
Ketamine	Rapid condensate reset (glutamate surge)	State filter (fast antidepressant)
Ayahuasca	Extended \(\alpha\) modulation + purge (somatic release)	Wound + adaptive layers
Microdosing	Subcritical perturbation (\(\alpha\) shift without phase transition)	Gentle global recalibration

2. DMN Dissolution as Condensate Softening¶

The default mode network maintains the self-model — the narrative condensate of "who I am." Under psilocybin, DMN connectivity decreases. In GL terms: \(W_0^{\text{self}}\) is temporarily reduced, but not to zero. The self-condensate softens, permitting information flow between normally separated cognitive regions.

This is NOT ego death (full collapse, \(W_0 = 0\)). It is condensate softening — temporary access to the critical point where new structures can form.

3. Integration as Condensate Reformation¶

The psychedelic experience itself is not the therapy — integration is. During the experience, the condensate softens. During integration, it reforms with new structure: new connections, new patterns, new ground state.

Without integration, the condensate simply returns to its previous configuration (the trip was "interesting but didn't change anything"). With integration, the new connections are stabilized by the GL energy barrier of the reformed condensate.

4. Connection to Cancer and ATRA¶

The principle is identical across scales: find the stuck condensate → soften it → allow reformation → stabilize the new state.

Cancer: ATRA softens the leukemic condensate → cells redifferentiate → new (healthy) condensate forms
Depression: Psilocybin softens the rumination condensate → new cognitive patterns emerge → integration stabilizes them
PTSD: MDMA softens the trauma condensate → reprocessing becomes possible → new emotional regulation patterns form

Same GL action. Same mechanism. Different substrate.

5. Safety and Risk¶

The GL framework also explains adverse outcomes: if \(\alpha\) is pushed too far past critical, the condensate collapses entirely (psychotic break, prolonged dissociation). Set, setting, and dosage control the depth of \(\alpha\) perturbation. Contraindications (psychosis history, certain medications) correspond to systems where the condensate is already near critical — any additional perturbation risks collapse.

6. What This Framework Does NOT Claim¶

It does not endorse unsupervised psychedelic use. Clinical context is essential.
It does not claim all mental health conditions respond to psychedelic therapy.
The GL parameters for specific compounds need empirical calibration.
Neuroimaging validation of condensate softening is needed.

References¶

Jean-Paul Niko · jeanpaulniko@proton.me · smarthub.my